# Estrogen Receptors and HER2 Levels' Expression in Luminal Metastatic Breast Cancer

> **NCT06243432** · — · UNKNOWN · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 600 (estimated)

## Conditions studied

- Advanced Breast Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06243432
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-03-01
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2024-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06243432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06243432, "Estrogen Receptors and HER2 Levels' Expression in Luminal Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06243432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*